TELA Bio, Inc. (TELA): Cash & Equivalents

Annual figures by period end, from SEC filings.

$50.84M
As of 2025-12-31
$30.42M
As of 2026-06-30
+6.6%
3-year compound annual growth
-7.3%
5-year compound annual growth
$74.39M2018-12-31: $17.28M2019-12-31: $45.30M2020-12-31: $74.39M2021-12-31: $43.93M2022-12-31: $42.02M2023-12-31: $46.73M2024-12-31: $52.67M2025-12-31: $50.84M$50.84M
2018-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$50.84M-3.5%2026-03-25, Balance as of period end
2024-12-31$52.67M+12.7%2026-03-25, Balance as of period end
2023-12-31$46.73M+11.2%2025-03-21, Balance as of period end
2022-12-31$42.02M-4.4%2024-03-22, Balance as of period end
2021-12-31$43.93M-40.9%2023-03-23, Balance as of period end
2020-12-31$74.39M+64.2%2022-03-23, Balance as of period end
2019-12-31$45.30M+162.2%2021-03-25, Balance as of period end
2018-12-31$17.28Mn/a2020-03-30, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
TELA Bio, Inc. (TELA)2025-12-31$50.84M-3.5%
PRO DEX Inc (PDEX)2026-06-30$8.19Mn/m
Sight Sciences, Inc. (SGHT)2025-12-31$91.97M-23.6%
Iradimed Corp (IRMD)2025-12-31$51.16M-2.1%
Delcath Systems, Inc. (DCTH)2025-12-31$43.45M+34.1%
AVITA Medical, Inc. (RCEL)2025-12-31$10.24M-27.1%
Pulmonx Corp (LUNG)2025-12-31$69.75M-1.6%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$99.71M-58.0%
NeuroPace Inc (NPCE)2025-12-31$21.69M+61.5%

Compare TELA, PDEX, SGHT, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗